Under the liquidity contract entrusted by Innate Pharma to Gilbert Dupont, the following assets appeared on the liquidity account as at June 30, 2015:
- 26,811 shares of Innate Pharma, and
- 334,840.22 euros in cash
As a reminder, at December 31, 2014, the following assets appeared on the liquidity account:
- 33,310 shares of Innate Pharma, and
- 233,366.36 euros in cash
| PR in English | 64.29 KB |
| Communiqué en français | 67.08 KB |